Omada Health (NASDAQ: OMDA) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.01) by 900 percent. This is a 133.33 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $87.835 million which beat the analyst consensus estimate of $80.190 million by 9.53 percent. This is a 43.12 percent increase over sales of $61.371 million the same period last year.